-- 
United Therapeutics’ Treprostinil Met Goal in Study

-- B y   P h i l   S e r a f i n o
-- 
2011-06-06T09:50:53Z

-- http://www.bloomberg.com/news/2011-06-06/united-therapeutics-treprostinil-met-goal-in-study-correct-.html
(Corrects type of study in second sentence.)  United Therapeutics Corp. (UTHR) ’s oral
version of treprostinil met the main goal of a late-stage study
in patients with pulmonary arterial hypertension, the company
said. A detailed analysis of adverse events in the double-blind
study is ongoing, the company said.  To contact the editor responsible for this story:
Phil Serafino at 
 pserafino@bloomberg.net  